Effects of an inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor on energy balance and glucose homeostasis in diet-induced obesity

被引：0
|
作者：
Arch, JRS
Wang, SJY
Birtles, S
Smith, DM
Turnbull, A
机构：
[1] Univ Buckingham, Clore Lab, Buckingham, England
[2] AstraZeneca, Macclesfield, Cheshire, England
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
650
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [1] 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, HIS-601 ameliorates insulin resistance in diet-induced obese mice
    Okazaki, Seiji
    Iwamura, Tomokatsu
    Takahashi, Takehiro
    Izawa, Akiko
    Itaba, Shoichi
    Inada, Chifumi
    Serizawa, Kanako
    Sakami, Satoshi
    Kawai, Koji
    Kainoh, Mie
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 245P - 245P
  • [2] Effects of 11β-hydroxysteroid dehydrogenase inhibition on body weight and glucose homeostasis in mice with diet-induced obesity
    Gault, V. A.
    Taylor, A. I.
    Irwin, N.
    McKillop, A. M.
    Flatt, P. R.
    DIABETOLOGIA, 2007, 50 : S272 - S272
  • [3] Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
    Liu, Juan
    Wang, Long
    Zhang, Aisen
    Di, Wenjuan
    Zhang, Xiao
    Wu, Lin
    Yu, Jing
    Zha, Juanmin
    Lv, Shan
    Cheng, Peng
    Hu, Miao
    Li, Yujie
    Qi, Hanmei
    Ding, Guoxian
    Zhong, Yi
    ENDOCRINE JOURNAL, 2011, 58 (03) : 199 - 209
  • [4] BVT.2733, a Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice
    Wang, Long
    Liu, Juan
    Zhang, Aisen
    Cheng, Peng
    Zhang, Xiao
    Lv, Shan
    Wu, Lin
    Yu, Jing
    Di, Wenjuan
    Zha, Juanmin
    Kong, Xiaocen
    Qi, Hanmei
    Zhong, Yi
    Ding, Guoxian
    PLOS ONE, 2012, 7 (07):
  • [5] 11beta-hydroxysteroid dehydrogenase type 1 activity determines the effects of glucocorticoids on bone
    Cooper, MS
    Blumsohn, A
    Goddard, PE
    Bartlett, WA
    Eastell, R
    Hewison, M
    Stewart, PM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (07) : 1330 - 1330
  • [6] Discovery of 11β-hydroxysteroid dehydrogenase type 1 inhibitor
    Hong, Sung Pyo
    Nam, Ky Youb
    Shin, Young June
    Kim, Kil Won
    Ahn, Soon Kil
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (17) : 3501 - 3506
  • [7] Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice
    Park, Ji Seon
    Rhee, Sang Dal
    Jung, Won Hoon
    Kang, Nam Sook
    Kim, Hee Youn
    Kang, Seung Kyu
    Ahn, Jin Hee
    Kim, Ki Young
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 691 (1-3) : 19 - 27
  • [8] Efficacious 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors in the Diet-Induced Obesity Mouse Model
    Wan, Zhao-Kui
    Chenail, Eva
    Xiang, Jason
    Li, Huan-Qiu
    Ipek, Manus
    Bard, Joel
    Svenson, Kristine
    Mansour, Tarek S.
    Xu, Xin
    Tian, Xianbin
    Suri, Vipin
    Hahm, Seung
    Xing, Yuzhe
    Johnson, Christian E.
    Li, Xiangping
    Qadri, Ariful
    Panza, Darrell
    Perreault, Mylene
    Tobin, James F.
    Saiah, Eddine
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (17) : 5449 - 5461
  • [9] Metyrapone is a competitive inhibitor of 11 beta-hydroxysteroid dehydrogenase type 1 reductase
    SampathKumar, R
    Yu, M
    Khalil, MW
    Yang, K
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 62 (2-3): : 195 - 199
  • [10] 11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates induced cardiomyopathy high-fat diet induced cardiomyopathy
    Huang, Min
    Liu, Juan
    Sheng, Yunlu
    Lv, Yifan
    Yu, Jing
    Qi, Hanmei
    Di, Wenjuan
    Lv, Shan
    Zhou, Suming
    Ding, Guoxian
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 125 : 106 - 116
12345